Oruka Therapeutics, Stock Today
| ORKA Stock | 20.75 0.25 1.22% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Oruka Therapeutics, is trading at 20.75 as of the 25th of November 2024, a 1.22% up since the beginning of the trading day. The stock's open price was 20.5. Oruka Therapeutics, has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days.Oruka Therapeutics, symbol was changed from ABIO on 3rd of September 2024. Equity ratings for Oruka Therapeutics, are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of December 2023 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of August 1997 | Classification Health Care |
Oruka Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 1000 K outstanding shares of which 783.78 K shares are now shorted by private and institutional investors with about 0.0 trading days to cover. More on Oruka Therapeutics,
Moving together with Oruka Stock
Moving against Oruka Stock
Oruka Stock Highlights
| Older Symbol | ABIO |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Average Analyst Recommendation | |
Oruka Therapeutics, (ORKA) is traded on NASDAQ Exchange in USA. It is located in null . Oruka Therapeutics, was previously known as ARCA Biopharma and was traded on NASDAQ Exchange under the symbol ABIO. Oruka Therapeutics, is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 888.26 M. Oruka Therapeutics, conducts business under Biotechnology sector and is part of Health Care industry. The entity has 1000 K outstanding shares of which 783.78 K shares are now shorted by private and institutional investors with about 0.0 trading days to cover.
Check Oruka Therapeutics, Probability Of Bankruptcy
Oruka Therapeutics, Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Oruka Therapeutics, market risk premium is the additional return an investor will receive from holding Oruka Therapeutics, long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (1.16) | |||
| Treynor Ratio | (0.04) |
Oruka Stock Against Markets
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oruka Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics,. If investors know Oruka will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oruka Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oruka Therapeutics, is measured differently than its book value, which is the value of Oruka that is recorded on the company's balance sheet. Investors also form their own opinion of Oruka Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Oruka Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oruka Therapeutics,'s market value can be influenced by many factors that don't directly affect Oruka Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oruka Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Oruka Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oruka Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.